License of OTC products to be subject to report

Published: 2002-04-12 06:58:00

Updated: 2002-04-12 06:58:00

The Korea Food and Drug Administration (KFDA) has announced that a series of new measures designed to ameliorate drug-related administration will be adopted in the second half of this year:

- The items to be reported will include pharmaceuticals in addition to medical devices;

- The pharma...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK